Keywords: immtech, pcp, drug, enters, ph, iii, trial

Immtech's PCP drug enters Ph III US trial

Article | 03 April 2006

Print This

USA-based Immtech Pharmaceuticals has initiated a domestic Phase III pivotal trial of its oral drug pafuramidine maleate in the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in